Juan Andrés Ávila Narváez, Pablo Andrés Salamea Avilés, Jorge Eduardo Ávila Narváez, Marcos Andrés Aguirre Vintimilla, Zoila Katherine Salazar Torres
{"title":"Caso Clínico: Neurofibromatosis Tipo 1, resolución quirúrgica","authors":"Juan Andrés Ávila Narváez, Pablo Andrés Salamea Avilés, Jorge Eduardo Ávila Narváez, Marcos Andrés Aguirre Vintimilla, Zoila Katherine Salazar Torres","doi":"10.14410/2020.12.2.CC.21","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Neurofibromatosis type 1, first described by von Recklinghausen in 1884, is an autosomal dominant genetically transmitted disease, caused by a spectrum of mutations in the NF-1 gen, with unpredictable evolution, that affects multiple organs and systems, such as the skin and the nervous system, also affecting child development and neurocognitive functions. It often requires complex management decisions from the physician that involve a multidisciplinary approach. CASE REPORTS: 9 year old female patient with a history of type 1 neurofibromatosis. She presented with a mass located in the anterior cervical region, occupying also the left hemithorax, compressing the anterior mediastinum, the trachea from its left side, the heart, and the left lung; the mass produced symptoms: dyspnea, dysphagia and pain, so surgical excision of the mass was scheduled. A left cervical-sternotomy-thoracotomy was performed, a 12 x 7cm mass, located at aortic arch level, closely adhered to the cervical-thoracic spine, was excised. EVOLUTION: During the surgical procedure, the patient had profuse bleeding, coming form the left common carotid colateral artery, so abdominal packing was performed, for later resolution. 24 hours later, bleeding control was achieved after the surgical re-intervention. The pathology lab results established that the mass was in fact a neurofibroma. Subsequent follow-up determined symptoms improvement, without late surgical complications. CONCLUSIONS: Neurofibromatosis is a congenital infrequent, disease, with a complex treatment. Although there is no definitive treatment for type 1 neurofibromatosis, comprehensive management can be achieved to improve the patient’s quality of life. Tumors can be surgically removed, although they often grow back.","PeriodicalId":417745,"journal":{"name":"Revista Médica del Hospital José Carrasco Arteaga","volume":"33 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Médica del Hospital José Carrasco Arteaga","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14410/2020.12.2.CC.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND: Neurofibromatosis type 1, first described by von Recklinghausen in 1884, is an autosomal dominant genetically transmitted disease, caused by a spectrum of mutations in the NF-1 gen, with unpredictable evolution, that affects multiple organs and systems, such as the skin and the nervous system, also affecting child development and neurocognitive functions. It often requires complex management decisions from the physician that involve a multidisciplinary approach. CASE REPORTS: 9 year old female patient with a history of type 1 neurofibromatosis. She presented with a mass located in the anterior cervical region, occupying also the left hemithorax, compressing the anterior mediastinum, the trachea from its left side, the heart, and the left lung; the mass produced symptoms: dyspnea, dysphagia and pain, so surgical excision of the mass was scheduled. A left cervical-sternotomy-thoracotomy was performed, a 12 x 7cm mass, located at aortic arch level, closely adhered to the cervical-thoracic spine, was excised. EVOLUTION: During the surgical procedure, the patient had profuse bleeding, coming form the left common carotid colateral artery, so abdominal packing was performed, for later resolution. 24 hours later, bleeding control was achieved after the surgical re-intervention. The pathology lab results established that the mass was in fact a neurofibroma. Subsequent follow-up determined symptoms improvement, without late surgical complications. CONCLUSIONS: Neurofibromatosis is a congenital infrequent, disease, with a complex treatment. Although there is no definitive treatment for type 1 neurofibromatosis, comprehensive management can be achieved to improve the patient’s quality of life. Tumors can be surgically removed, although they often grow back.
背景:1型神经纤维瘤病由von Recklinghausen于1884年首次描述,是一种常染色体显性遗传遗传病,由NF-1基因的一系列突变引起,具有不可预测的进化,可影响多个器官和系统,如皮肤和神经系统,也影响儿童发育和神经认知功能。它通常需要医生做出复杂的管理决策,涉及多学科方法。病例报告:9岁女性患者与1型神经纤维瘤病的历史。她在颈椎前区出现肿块,也占据了左半胸,压迫前纵隔、气管左侧、心脏和左肺;肿块产生了呼吸困难、吞咽困难和疼痛等症状,因此计划手术切除肿块。行左侧颈胸开胸术,切除位于主动脉弓水平、与颈胸椎紧密粘附的12 x 7cm肿物。进展:在手术过程中,患者出现大量出血,从左侧颈总侧动脉流出,因此进行了腹部填塞,以备以后解决。24小时后,再次手术干预后出血得到控制。病理化验结果证实肿块实际上是神经纤维瘤。后续随访确定症状改善,无后期手术并发症。结论:神经纤维瘤病是一种罕见的先天性疾病,治疗复杂。虽然1型神经纤维瘤病没有明确的治疗方法,但综合管理可以提高患者的生活质量。肿瘤可以通过手术切除,尽管它们经常会长回来。